{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:18:44Z","timestamp":1792455524919,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cca.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T02:06:20Z","timestamp":1642125980000},"page":"61-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Hyperlipidemia and hypothyroidism"],"prefix":"10.1016","volume":"527","author":[{"given":"Xin","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2022.01.006_b0005","doi-asserted-by":"crossref","first-page":"686317","DOI":"10.3389\/fendo.2021.686317","article-title":"Diagnosis and Management of Central Congenital Hypothyroidism","volume":"12","author":"Lauffer","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"10.1016\/j.cca.2022.01.006_b0010","first-page":"e17301","article-title":"Comparison of Lipid Profile in Patients With and Without Subclinical Hypothyroidism","volume":"13","author":"Ejaz","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.cca.2022.01.006_b0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamainternmed.2013.12188","article-title":"Thyroid function testing in patients with newly diagnosed hyperlipidemia","volume":"174","author":"Willard","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.cca.2022.01.006_b0020","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1136\/bmj.l2006","article-title":"Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline","volume":"365","author":"Bekkering","year":"2019","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0025","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.3390\/ijms22094633","article-title":"Novel Therapeutical Approaches to Managing Atherosclerotic Risk","volume":"22","author":"Giglio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"03","key":"10.1016\/j.cca.2022.01.006_b0030","first-page":"220","article-title":"High thyroid-stimulating hormone level is associated with the risk of developing atherosclerosis in subclinical hypothyroidism","volume":"47","author":"Gao","year":"2015","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4158\/EP15844.OR","article-title":"Thyroid-Stimulating Hormone Levels Are Inversely Associated with Serum Total Bile Acid Levels: A Cross-Sectional Study","volume":"22","author":"Song","year":"2016","journal-title":"Endocr. Pract."},{"issue":"8","key":"10.1016\/j.cca.2022.01.006_b0040","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/thy.2016.0010","article-title":"A Worthy Finding: Decrease in Total Cholesterol and Low-Density Lipoprotein Cholesterol in Treated Mild Subclinical Hypothyroidism","volume":"26","author":"Zhao","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bj.2018.02.002","article-title":"Subclinical hypothyroidism and metabolic risk factors association: A health examination-based study in northern Taiwan","volume":"41","author":"Liu","year":"2018","journal-title":"Biomed. J."},{"issue":"2","key":"10.1016\/j.cca.2022.01.006_b0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4274\/jcrpe.3719","article-title":"Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children","volume":"9","author":"Unal","year":"2017","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"6","key":"10.1016\/j.cca.2022.01.006_b0055","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.ejim.2012.05.007","article-title":"Postprandial hyperlipidemia in overt and subclinical hypothyroidism","volume":"23","author":"Arikan","year":"2012","journal-title":"Eur. J. Intern. Med."},{"issue":"29","key":"10.1016\/j.cca.2022.01.006_b0060","doi-asserted-by":"crossref","first-page":"e4291","DOI":"10.1097\/MD.0000000000004291","article-title":"Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism","volume":"95","author":"Dong","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0065","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2017-00986","article-title":"Thyroid Function, Cardiovascular Risk Factors, and Incident Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"102","author":"Martin","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.cca.2022.01.006_b0070","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/thy.2012.0013","article-title":"Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study","volume":"22","author":"Tognini","year":"2012","journal-title":"Thyroid"},{"issue":"01","key":"10.1016\/j.cca.2022.01.006_b0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/a-1191-7953","article-title":"Correlation Between Serum TSH Levels Within Normal Range and Serum Lipid Profile","volume":"53","author":"Luxia","year":"2021","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"10.1016\/j.cca.2022.01.006_b0080","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1194\/jlr.M047654","article-title":"Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver","volume":"56","author":"Zhang","year":"2015","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.cca.2022.01.006_b0085","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.euroneuro.2015.04.028","article-title":"Vitamin D deficiency exacerbates atypical antipsychotic-induced metabolic side effects in rats: involvement of the INSIG\/SREBP pathway","volume":"25","author":"Dang","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"36","key":"10.1016\/j.cca.2022.01.006_b0090","doi-asserted-by":"crossref","first-page":"34114","DOI":"10.1074\/jbc.M305417200","article-title":"Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2)","volume":"278","author":"Shin","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.cca.2022.01.006_b0095","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1172\/JCI60580","article-title":"Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy","volume":"122","author":"Sinha","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur. J. Biochem."},{"issue":"6","key":"10.1016\/j.cca.2022.01.006_b0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1507\/endocrj.EJ19-0455","article-title":"Gestational hypothyroidism elicits more pronounced lipid dysregulation in mice than pre-pregnant hypothyroidism","volume":"67","author":"Zhou","year":"2020","journal-title":"Endocr. J."},{"issue":"27","key":"10.1016\/j.cca.2022.01.006_b0110","doi-asserted-by":"crossref","first-page":"13482","DOI":"10.1016\/S0021-9258(18)68263-8","article-title":"Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA","volume":"263","author":"Davidson","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cca.2022.01.006_b0115","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1210\/en.2012-1572","article-title":"Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway","volume":"153","author":"Goldberg","year":"2012","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0120","first-page":"1216","article-title":"Activation of the hepatic LDL receptor promoter by thyroid hormone","volume":"1771","author":"Lopez","year":"2007","journal-title":"BBA"},{"issue":"2","key":"10.1016\/j.cca.2022.01.006_b0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2014.05.931","article-title":"CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism","volume":"235","author":"Dong","year":"2014","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbrc.2018.01.187","article-title":"Liver-specific deletion of TSHR inhibits hepatic lipid accumulation in mice","volume":"497","author":"Zhou","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0135","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.23800","volume":"52","author":"Tian","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cca.2022.01.006_b0140","doi-asserted-by":"crossref","first-page":"e0124951","DOI":"10.1371\/journal.pone.0124951","article-title":"AICAR-Induced Activation of AMPK Inhibits TSH\/SREBP-2\/HMGCR Pathway in Liver","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.cca.2022.01.006_b0145","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1096\/fj.201700161R","article-title":"TSHB mRNA is linked to cholesterol metabolism in adipose tissue","volume":"31","author":"Moreno\u2010Navarrete","year":"2017","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0150","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.metabol.2009.08.018","article-title":"Thyroid-stimulating hormone stimulates lipolysis in adipocytes in culture and raises serum free fatty acid levels in vivo","volume":"59","author":"Gagnon","year":"2010","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.cca.2022.01.006_b0155","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2014.12.006","article-title":"Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2\/HNF-4alpha\/CYP7A1 axis","volume":"62","author":"Song","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2022.01.006_b0160","doi-asserted-by":"crossref","first-page":"696961","DOI":"10.3389\/fphar.2021.696961","article-title":"Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression","volume":"12","author":"Tomacha","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2022.01.006_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2016.04.023","article-title":"Triiodothyronine enhances accumulation of intracellular lipids in adipocytes through thyroid hormone receptor alpha via direct and indirect mechanisms","volume":"431","author":"Gambo","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cca.2022.01.006_b0170","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fphys.2017.00706","article-title":"Both 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet","volume":"8","author":"Senese","year":"2017","journal-title":"Front. Physiol."},{"issue":"36","key":"10.1016\/j.cca.2022.01.006_b0175","doi-asserted-by":"crossref","first-page":"28156","DOI":"10.1074\/jbc.M110.146241","article-title":"Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner","volume":"285","author":"Gauthier","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmet.2017.10.008","article-title":"Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis","volume":"27","author":"Sanchez-Gurmaches","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.cca.2022.01.006_b0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2019.08.005","article-title":"Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease","volume":"498","author":"Su","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2009.07.003","article-title":"Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia","volume":"59","author":"Stein","year":"2010","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0195","doi-asserted-by":"crossref","first-page":"14578","DOI":"10.1038\/s41598-020-71569-8","article-title":"Genome-wide association study for circulating fibroblast growth factor 21 and 23","volume":"10","author":"Chuang","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0200","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1111\/jpn.12699","article-title":"High non-esterified fatty acid concentrations promote expression and secretion of fibroblast growth factor 21 in calf hepatocytes cultured in vitro","volume":"102","author":"Wang","year":"2018","journal-title":"J. Anim. Physiol. Anim. Nutr. (Berl.)"},{"key":"10.1016\/j.cca.2022.01.006_b0205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejim.2016.03.028","article-title":"Levothyroxine treatment restored the decreased circulating fibroblast growth factor 21 levels in patients with hypothyroidism","volume":"31","author":"Wang","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.cca.2022.01.006_b0210","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fendo.2018.00800","article-title":"Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients","volume":"9","author":"Xiao","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"10.1016\/j.cca.2022.01.006_b0215","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1507\/endocrj.EJ12-0427","article-title":"Plasma FGF21 levels are increased in patients with hypothyroidism independently of lipid profile","volume":"60","author":"Lee","year":"2013","journal-title":"Endocr. J."},{"issue":"3","key":"10.1016\/j.cca.2022.01.006_b0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/JOE-14-0440","article-title":"Thyroid hormone receptor regulates most genes independently of fibroblast growth factor 21 in liver","volume":"224","author":"Zhang","year":"2015","journal-title":"J. Endocrinol."},{"issue":"19","key":"10.1016\/j.cca.2022.01.006_b0225","doi-asserted-by":"crossref","first-page":"14078","DOI":"10.1074\/jbc.C110.107375","article-title":"Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner","volume":"285","author":"Adams","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.cca.2022.01.006_b0230","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.1006962107","article-title":"Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway","volume":"107","author":"Chau","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.cca.2022.01.006_b0235","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/en.2013-1902","article-title":"Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo","volume":"155","author":"Domouzoglou","year":"2014","journal-title":"Endocrinology"},{"issue":"40","key":"10.1016\/j.cca.2022.01.006_b0240","doi-asserted-by":"crossref","first-page":"34559","DOI":"10.1074\/jbc.M111.285965","article-title":"Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0245","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.cca.2022.01.006_b0250","doi-asserted-by":"crossref","first-page":"e65763","DOI":"10.1371\/journal.pone.0065763","article-title":"LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys","volume":"8","author":"Adams","year":"2013","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0255","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1210\/en.2012-1211","article-title":"Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys","volume":"153","author":"Veniant","year":"2012","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.cca.2022.01.006_b0260","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.cca.2022.01.006_b0265","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3390\/nu10111699","article-title":"ChREBP Reciprocally Regulates Liver and Plasma Triacylglycerol Levels in Different Manners","volume":"10","author":"Iizuka","year":"2018","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.cca.2022.01.006_b0270","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cmet.2012.11.001","article-title":"Circulating fibroblast growth factors as metabolic regulators\u2013a critical appraisal","volume":"16","author":"Angelin","year":"2012","journal-title":"Cell Metab."},{"issue":"39","key":"10.1016\/j.cca.2022.01.006_b0275","doi-asserted-by":"crossref","first-page":"e5001","DOI":"10.1097\/MD.0000000000005001","article-title":"Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism","volume":"95","author":"Lai","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.cca.2022.01.006_b0280","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bbrc.2013.11.126","article-title":"SREBP-2 negatively regulates FXR-dependent transcription of FGF19 in human intestinal cells","volume":"443","author":"Miyata","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2022.01.006_b0285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cca.2021.03.024","article-title":"MicroRNA in cardio-metabolic disorders","volume":"518","author":"Su","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2022.01.006_b0290","doi-asserted-by":"crossref","first-page":"707529","DOI":"10.3389\/fcvm.2021.707529","article-title":"Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms","volume":"8","author":"Malekmohammad","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cca.2022.01.006_b0295","doi-asserted-by":"crossref","first-page":"108878","DOI":"10.1016\/j.steroids.2021.108878","article-title":"Regulation of cholesterol biosynthesis and lipid metabolism: A microRNA management perspective","volume":"173","author":"Bhattarai","year":"2021","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0300","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2013.09.116","article-title":"Thyroid hormone negatively regulates CDX2 and SOAT2 mRNA expression via induction of miRNA-181d in hepatic cells","volume":"440","author":"Yap","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0305","first-page":"5635","article-title":"Serum microRNA miR-206 is decreased in hyperthyroidism and mediates thyroid hormone regulation of lipid metabolism in HepG2 human hepatoblastoma cells","volume":"17","author":"Zheng","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cca.2022.01.006_b0310","article-title":"Identification of a PCSK9-LDLR disruptor peptide with in vivo function","author":"Brousseau","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.cca.2022.01.006_b0315","doi-asserted-by":"crossref","first-page":"682389","DOI":"10.3389\/fcvm.2021.682389","article-title":"The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.cca.2022.01.006_b0320","doi-asserted-by":"crossref","first-page":"e64145","DOI":"10.1371\/journal.pone.0064145","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)","volume":"8","author":"Canuel","year":"2013","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.cca.2022.01.006_b0325","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1194\/jlr.M051664","article-title":"Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans","volume":"55","author":"Bonde","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0330","doi-asserted-by":"crossref","first-page":"17167","DOI":"10.1038\/s41598-019-53603-6","article-title":"PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2022.01.006_b0335","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2017.07.006","article-title":"Thyroid stimulating hormone exhibits the impact on LDLR\/LDL-c via up-regulating hepatic PCSK9 expression","volume":"76","author":"Gong","year":"2017","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.cca.2022.01.006_b0340","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/thy.2012.0434","article-title":"Adiposity blunts the positive relationship of thyrotropin with proprotein convertase subtilisin-kexin type 9 levels in euthyroid subjects","volume":"23","author":"Kwakernaak","year":"2013","journal-title":"Thyroid"},{"issue":"27","key":"10.1016\/j.cca.2022.01.006_b0345","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","article-title":"ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis","volume":"279","author":"Schaap","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.cca.2022.01.006_b0350","doi-asserted-by":"crossref","first-page":"27533","DOI":"10.1074\/jbc.M503139200","article-title":"Thyroid hormone regulates the hypotriglyceridemic gene APOA5","volume":"280","author":"Prieur","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0355","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4065\/73.9.837","article-title":"Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism","volume":"73","author":"Triguero","year":"1998","journal-title":"Mayo Clin. Proc."},{"issue":"10","key":"10.1016\/j.cca.2022.01.006_b0360","doi-asserted-by":"crossref","first-page":"890","DOI":"10.5551\/jat.12757","article-title":"Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease","volume":"19","author":"Mugii","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0365","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.2010.0313","article-title":"Lipid metabolism in subclinical hypothyroidism: plasma kinetics of triglyceride-rich lipoproteins and lipid transfers to high-density lipoprotein before and after levothyroxine treatment","volume":"21","author":"Sigal","year":"2011","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0370","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.amjmed.2004.04.027","article-title":"Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism","volume":"117","author":"Ito","year":"2004","journal-title":"Am. J. Med."},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0375","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1089\/thy.2012.0457","article-title":"Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism","volume":"23","author":"Moon","year":"2013","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2012.12.021","article-title":"Lipopolysaccharide downregulates CD91\/low-density lipoprotein receptor-related protein 1 expression through SREBP-1 overexpression in human macrophages","volume":"227","author":"Costales","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2022.01.006_b0385","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1038\/srep07633","article-title":"Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3","volume":"5","author":"Ma","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cca.2022.01.006_b0390","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jhep.2014.06.037","article-title":"Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity","volume":"61","author":"Yan","year":"2014","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.cca.2022.01.006_b0395","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jacl.2017.08.015","article-title":"Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function","volume":"11","author":"Jung","year":"2017","journal-title":"J. Clin. Lipidol."},{"issue":"3","key":"10.1016\/j.cca.2022.01.006_b0400","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s11033-021-06248-6","article-title":"ANGPLT3 in cardio-metabolic disorders","volume":"48","author":"Su","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0405","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12944-018-0659-y","article-title":"New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases","volume":"17","author":"Su","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"17","key":"10.1016\/j.cca.2022.01.006_b0410","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1074\/jbc.M512554200","article-title":"The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone","volume":"281","author":"Fugier","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.cca.2022.01.006_b0415","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"Myocardial Infarction Genetics Consortium, ANGPTL3 Deficiency and Protection Against Coronary Artery Disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"36","key":"10.1016\/j.cca.2022.01.006_b0420","doi-asserted-by":"crossref","first-page":"27561","DOI":"10.1074\/jbc.M110.144279","article-title":"Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases","volume":"285","author":"Liu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2022.01.006_b0425","article-title":"The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding","volume":"5","author":"Mysling","year":"2016","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0430","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/ATVBAHA.118.312021","article-title":"Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State","volume":"39","author":"Tikkanen","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.cca.2022.01.006_b0435","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1194\/jlr.M054882","article-title":"Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion","volume":"56","author":"Wang","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2022.01.006_b0440","doi-asserted-by":"crossref","first-page":"3814687","DOI":"10.1155\/2019\/3814687","article-title":"Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism","volume":"2019","author":"Yang","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.cca.2022.01.006_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-015-0324-y","article-title":"Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study","volume":"15","author":"Chung","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.cca.2022.01.006_b0450","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1210\/en.2016-1894","article-title":"ANGPTL8 Blockade With a Monoclonal Antibody Promotes Triglyceride Clearance, Energy Expenditure, and Weight Loss in Mice","volume":"158","author":"Gusarova","year":"2017","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cca.2022.01.006_b0455","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s42000-019-00095-8","article-title":"Decreased circulating levels of ANGPTL8 in Graves' disease patients","volume":"18","author":"Li","year":"2019","journal-title":"Hormones (Athens)"},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0460","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/auto.26126","article-title":"Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism","volume":"10","author":"Tseng","year":"2014","journal-title":"Autophagy"},{"issue":"48","key":"10.1016\/j.cca.2022.01.006_b0465","doi-asserted-by":"crossref","first-page":"19751","DOI":"10.1073\/pnas.1217552109","article-title":"Atypical angiopoietin-like protein that regulates ANGPTL3","volume":"109","author":"Quagliarini","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0470","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1194\/jlr.M082099","article-title":"CRISPR\/Cas9-mediated Angptl8 knockout suppresses plasma triglyceride concentrations and adiposity in rats","volume":"59","author":"Izumi","year":"2018","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.cca.2022.01.006_b0475","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1194\/jlr.M075689","article-title":"ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance","volume":"58","author":"Haller","year":"2017","journal-title":"J. Lipid Res."},{"issue":"16","key":"10.1016\/j.cca.2022.01.006_b0480","doi-asserted-by":"crossref","first-page":"9494","DOI":"10.1073\/pnas.1531901100","article-title":"Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration","volume":"100","author":"Oike","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.cca.2022.01.006_b0485","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.metabol.2015.06.015","article-title":"Influence of thyroid dysfunction on serum levels of angiopoietin-like protein 6","volume":"64","author":"Lim","year":"2015","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0490","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4093\/dmj.2018.0080","article-title":"Increased Serum Angiopoietin-Like 6 Ahead of Metabolic Syndrome in a Prospective Cohort Study","volume":"43","author":"Namkung","year":"2019","journal-title":"Diab. Metab. J."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0495","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/JOE-16-0549","article-title":"ANGPTL6 expression is coupled with mitochondrial OXPHOS function to regulate adipose FGF21","volume":"233","author":"Kang","year":"2017","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.cca.2022.01.006_b0500","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1074\/jbc.M307583200","article-title":"Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4","volume":"279","author":"Ge","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0505","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1194\/jlr.D071787","article-title":"Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry","volume":"58","author":"Reimund","year":"2017","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.cca.2022.01.006_b0510","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/ATVBAHA.108.176917","article-title":"ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk","volume":"28","author":"Talmud","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0515","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Blood","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cca.2022.01.006_b0520","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2011.04.028","article-title":"Thyroid hormone enhances the ability of serum to accept cellular cholesterol via the ABCA1 transporter","volume":"218","author":"Boone","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2022.01.006_b0525","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12944-016-0293-5","article-title":"Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study","volume":"15","author":"Yang","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.cca.2022.01.006_b0530","doi-asserted-by":"crossref","first-page":"e3355","DOI":"10.1210\/clinem\/dgaa411","article-title":"HDL Cholesterol Efflux Capacity is Impaired in Severe Short-Term Hypothyroidism Despite Increased HDL Cholesterol","volume":"105","author":"van der Boom","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.cca.2022.01.006_b0535","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0021-9150(80)90251-8","article-title":"Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man","volume":"36","author":"Kuusi","year":"1980","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.cca.2022.01.006_b0540","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/thy.2015.0443","article-title":"Postprandial Studies Uncover Differing Effects on HDL Particles of Overt and Subclinical Hypothyroidism","volume":"26","author":"McGowan","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.cca.2022.01.006_b0545","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.12659\/MSM.898134","article-title":"Serum Lipid Transfer Proteins in Hypothyreotic Patients Are Inversely Correlated with Thyroid-Stimulating Hormone (TSH) Levels","volume":"22","author":"Skoczy\u0144ska","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.cca.2022.01.006_b0550","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1006\/abbi.1995.0061","article-title":"Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone","volume":"323","author":"Ness","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.cca.2022.01.006_b0555","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.25861","article-title":"Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5\/G8 complex","volume":"56","author":"Bonde","year":"2012","journal-title":"Hepatology"},{"issue":"29","key":"10.1016\/j.cca.2022.01.006_b0560","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1073\/pnas.0504379102","article-title":"Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice","volume":"102","author":"Johansson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cca.2022.01.006_b0565","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.atherosclerosis.2013.03.009","article-title":"Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus","volume":"228","author":"Triolo","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:02:33Z","timestamp":1757862153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":113,"alternative-id":["S0009898122000158"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.01.006","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperlipidemia and hypothyroidism","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}